National Gaucher Foundation - Gaucher Disease
Slideshow Image 1
Slideshow Image 2
Slideshow Image 3

Actelion

Other information/Services

Zavesca® Financial Support

Zavesc® a Patient Support is a financial assistance program available to eligible patients who have been prescribed Zavesca® (miglustat). This program may cover your co-pay and out-of-pocket costs while you are taking Zavesca®, so there is no cost to you.

For more information about Zavesca® Financial Support, call CuraScript's Zavesca® Team Monday through Friday, 8 am to 6 pm Eastern time (5 am to 3 pm Pacific time). Even after hours, there is always a CuraScript representative on call to help you.

Zavesca® Patient Support

CuraScript Zavesca® Team

Zavesca® (miglustat) is distributed by CuraScript, Inc., a specialty pharmacy that ensures that patients have continued access to their medication. CuraScript's Zavesca® team is made up of registered nurses and pharmacists who are available to answer your questions about Zavesca®.

For more information about Zavesca®, Zavesca® Financial Support, or CuraScript, call CuraScript's Zavesca® Team Monday through Friday, 8 am to 6 pm Eastern time (5 am to 3 pm Pacific time). Even after hours, there is always a CuraScript representative on call to help you. Call Curascript at 1-888-281-5582.

Clinical Advocacy Managers: Actelion also has a team of dedicated nurses, called Clinical Advocacy Managers, or CAMs, who attend patient support group meetings. The CAMs provide education and support to patients and families of patients with type 1 Gaucher disease.

Actelion Medical Information: Actelion Medical Information is available to provide answers to questions from health care professionals and patients about Zavesca® for type 1 Gaucher disease. Please call 1-866-ACTELION (228-3546), Monday through Friday, 11 am to 8 pm Eastern time (8 am to 5 pm Pacific time).

 

Who We Are
Actelion Pharmaceuticals Ltd is a biopharmaceutical company headquartered in Allschwil/Basel, Switzerland, focusing on the discovery, development and commercialization of innovative treatments to serve high unmet medical needs.

Contact information:
Actelion Pharmaceuticals US, Inc
5000 Shoreline Court #200
South San Francisco, CA 94080
T: 650-624-6900
www.actelion.com

Zavesca® Website:
www.zavesca.com